PowerShares Dynamic Pharmaceuticals Portfolio (PJP)

Delayed Data
As of Feb 16
 +0.22 / +0.33%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 23 U.S. pharmaceuticals companies. These companies are engaged principally in the research- development- manufacture- sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Solid Q4 Earnings Drive Pharma ETF Outlook
Feb 09 / Zacks.com - Paid Partner Content


1 month-1.39% 3 years-1.06%
3 months+7.52% 5 years+14.56%
1 year+10.60% Since inception+14.11%
Data through 02/17/2018

Quote Details

Previous close$66.51
Open day’s range66.45 – 67.18
Net asset value (NAV)66.73 (02/16/2018)
Daily volume50,273
Average volume (3 months)59,681
Data as of 3:59pm ET, 02/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+14.56%+17.28%
Expense Gross exp ratio0.56%1.31%
Risk 5 year sharpe ratio0.911.11
Net assets$644.0M$3.2B
Average market cap$15.3B$9.5B
Average P/E20.322.6
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ABBV AbbVie5.46%
GILD Gilead Sciences5.29%
ABT Abbott Laboratories5.12%
AMGN Amgen5.03%
PFE Pfizer4.80%
BMY Bristol-Myers Squibb4.70%
JNJ Johnson & Johnson4.62%
LLY Eli Lilly and Co4.47%
ENTA Enanta Pharmaceuticals Inc4.47%
CORT Corcept Therapeutics Inc3.25%